Researchers compared corneal endothelium damage after Ahmed glaucoma valve implantation with anterior chamber or ciliary sulcus placement.

Dr. Janet Serle discusses the newest IOP-lowering glaucoma medications, including latanoprostene bunod or LBN, netarsudil, fixed-dose combination netarsudil/latanoprost, and the bimatoprost implant.

This week, a treatment for retinitis pigmentosa receives orphan drug status, the OMNI platform becomes the first MIGS device cleared for open-angle glaucoma and researchers integrate biosensors into soft contact lenses.

This week, a travoprost intracameral implant shows encouraging phase 1 results, the ILM could play a key role in repairing damaged retinas and acupuncture treatment leaves a patient seeing lights.

This week, a new study finds SARS-CoV-2 in donor corneal tissues, first-in-class treatments for glaucoma and dry eye show promise and researchers discover rosette-shaped deposits on the surface of an IOL.

Recommendations distilled from the PPPs for the diagnosis and management of primary open-angle glaucoma, primary open-angle glaucoma suspect, and primary angle-closure disease

In this presentation from AGS 2020, Dr. Keith Barton discusses bleb needling and bleb revision of the XEN Gel Stent, a MIGS device for open-angle glaucoma.

In this presentation from AGS 2020, Dr. Carla Siegfried describes surgical techniques and concepts that lead to a successful trabeculectomy bleb, including conjunctival closure and the use of mytomycin C (MMC).

In this presentation from AGS 2020, Dr. E. Randy Craven demonstrates the surgical techniques and outcomes that lead to a successful XEN bleb.